Tobira Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
29 Sep 2016	Form 3: Allergan plc, 10% owner and 2 others Holds 0 shares of Common Stock, par value $0.001
22 Sep 2016	Form 3: Pentwater Capital Management Lp, 10% owner Holds 1,909,000 shares of Common Stock, par value $0.001 per share
18 Dec 2015	Form 3: Shah Nimesh, 10% owner Holds 38,094 shares of Common Stock
07 May 2015	Form 3: Weber Eckard, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Melincoff Gwen A, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Peetz Christopher, Chief Financial Officer Holds 0 shares of Common Stock
06 May 2015	Form 3: Jenkins Helen, Chief Operating Officer Holds 0 shares of Common Stock
06 May 2015	Form 3: Lefebvre Eric, Chief Medical Officer Holds 0 shares of Common Stock
06 May 2015	Form 3: Cooper Jeffrey H, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Heron Patrick J, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Frazier Healthcare V, Lp, 10% owner Holds 0 shares of Common Stock
06 May 2015	Form 3: Fischer Laurent, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Brosgart Carol L, Director Holds 0 shares of Common Stock
06 May 2015	Form 3: Novo A/S, 10% owner Holds 1,858,364 shares of COMMON STOCK
06 May 2015	Form 3: Dp Vii Associates Lp, 10% owner and 6 others Holds 47,613 shares of Common Stock
06 May 2015	Form 3: Domain Parters Vii L P, 10% owner and 6 others Holds 3,275,545 shares of Common Stock
16 Jun 2014	Form 3: Fromkin Andrew J., Director Holds 100 shares of Common Stock
21 May 2014	Form 3: Pelliccione Nicholas J., Sr. VP of Regulatory Affairs Holds 0 shares of No securities are beneficially owned
07 May 2014	Form 3: Elsey R Don, Sr. VP/Chief Financial Officer Holds 0 shares of No securities are beneficially owned
10 Feb 2014	Form 3: Bvf Partners L P/IL, 10% owner and 4 others Holds 1,979,615 shares of Common stock, $0.001 par value

Comments